TGFB1 and non-small cell lung carcinoma: Interestingly, although the non-small cell lung cancer line we used is also able to secrete TGF-β1, its constitutive migration does not seem to be affected by the TGF-β receptor I inhibitor (at least not at the concentration that is effective for MDA), suggesting that its migration is not solely dependent on TGF-β1.